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ABSTRACT 
Previous work has emphasized the crucial role of retinoic acid (RA) in the ontogenesis of 
the vast majority of mesenchymal structures derived from the neural crest cells (NCC), 
which migrate through, or populate, the frontonasal process and branchial arches. 
Using somatic mutagenesis in the mouse, we have selectively ablated two or three 
retinoic acid receptors (i.e., RAR! /RAR", RAR! /RAR#  and RAR! /RAR" /RAR#) in 
NCC. By rigorously analysing these mutant mice, we found that survival and migration 
of NCC is normal until gestational day 10.5, suggesting that RAR-dependent signalling 
is not intrinsically required for the early steps of NCC development. However, ablation 
of Rara and Rarg genes in NCC yields an agenesis of the median portion of the face, 
demonstrating that RAR! and RAR" act cell-autonomously in post-migratory NCC to 
control the development of structures derived from the frontonasal process. In contrast, 
ablation of the three Rar genes in NCC leads to less severe defects of the branchial 
arches derived structures compared to Rar compound null mutants. Therefore, RARs 
exert a function in the NCC as well as in a separated cell population. This work 
demonstrates that RARs use distinct mechanisms to pattern cranial NCC. 
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INTRODUCTION 
The morphogenesis of the craniofacial region results from complex developmental processes 
involving the migration of neural crest cells (NCC) and their subsequent differentiation 
through interactions with endoderm and ectoderm (Veitch et al., 1999; Trainor and Krumlauf, 
2001). Cranial NCC arise from fore-, mid- and hindbrain in distinct migratory streams. Fore- 
and midbrain NCC give rise to the frontonasal skeleton, whereas pre-otic hindbrain 
populations colonize the first two branchial arches (BA), where they differentiate to form 
skeletal elements of the jaw, middle ear and tongue. Cardiac NCC participate in the 
development of aortic arch arteries, as well as thymus, thyroid and parathyroid glands (Le 
Douarin et al., 1993; Santagati and Rijli, 2003). Since patterning and morphogenesis of these 
cranio-facial structures require a finely orchestrated series of tissue interactions (Graham and 
Smith, 2001; Trainor and Krumlauf, 2001), perturbation of different processes may yield 
similar developmental abnormalities. For instance, inactivation of genes expressed in either 
NCC, endoderm or ectoderm, results in similar cardiovascular defects, as remodelling of BA 
arteries into the definitive arterial vessels and heart outflow tract requires coordinated 
communication between NCC, endoderm and ectoderm (Depew et al., 1999; Lindsay et al., 
2001; Abu-Issa et al., 2002; Stalmans et al., 2003). 
Malformations of cranial NCC-derived structures are generated upon impairment of retinoic 
acid (RA) signalling in various vertebrate species (Lohnes et al., 1994; Mark et al., 1998; 
Schneider et al., 2001; Jiang et al., 2002a; Jiang et al., 2002b; Kopinke et al., 2006; Halilagic 
et al., 2007; Vieux-Rochas et al., 2007). The effects of RA on embryonic development are 
mediated by heterodimers between RA receptor (RAR) isotypes (RAR!, " and #) that are 
widely expressed in the embryo (Mollard et al., 2000; Dollé, 2009) and rexinoid receptors 
(RXRs) (Chambon, 1996; Mark et al., 2009). The requirement of RARs for pattern formation, 
differentiation, proliferation and apoptosis during organogenesis has been investigated 
through generation and analysis of Rar-null mouse models (Mark et al., 2009). These studies 
have shown that Rara/g-null mutants display malformations in a large variety of structures 
derived from cranial and cardiac NCC (Lohnes et al., 1994; Mendelsohn et al., 1994; 
Ghyselinck et al., 1997). In particular, structures derived from the frontonasal process are 
agenic in these mutants, resulting in a median facial cleft. In Rara/g-null and Rara/b-null 
mutants, BA2 or BA3 to BA6 are hypoplastic and the laryngeal cartilages are malformed 
(Mendelsohn et al., 1994; Dupé et al., 1999b; Wendling et al., 2001). The aortico-pulmonary 
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septum and derivatives of the 3rd, 4th, and 6th aortic arches are also consistently altered in these 
mutants, leading to persistent truncus arteriosus and to a variety of abnormal arterial patterns 
(Mendelsohn et al., 1994; Jiang et al., 2002a). In addition, various forms of parathyroid or 
thymic ectopia or agenesis are observed (Mendelsohn et al., 1994; Ghyselinck et al., 1997). 
Altogether, these observations led to the proposal that cranial NCC giving rise to 
mesenchymal derivatives are major targets of RA action (Mark et al., 1998). 
While previous work has demonstrated that RA is produced by the ventral epithelium of the 
frontonasal process and then targets the cranial NCC (Schneider et al., 2001), the question 
whether RARs have their functions in both cranial NCC and craniofacial ectoderm is still 
unclear. In addition, various data favoured the involvement of interactions between the arch 
endoderm and the NCC in the patterning of BAs (Graham et al., 2005). In experimental 
approaches where RA signalling is impaired, hypoplasia of BA3-4 is always correlated with 
changes in expression of genes that are crucial for the normal patterning of BAs, notably 
Hoxa1 and Hoxb1 in NCC and endoderm, as well as Pax1 and Pax9 in endoderm (Peters et 
al., 1998; Dupé et al., 1999b; Wendling et al., 2000; Vermot et al., 2003; Mark et al., 2004). 
These data strongly suggest that RA exerts at least part of its action in the endoderm. 
Furthermore, a previous study using specific inactivation of RXR! in the NCC suggests that 
the persistent truncus arteriosus phenotype would be non cell-autonomous for the NCC (Jiang 
et al., 2002a). However, the actual involvement of each of the RARs in NCCs versus other 
craniofacial tissues has not been deciphered. The mouse knockout models that have been 
analyzed so far did not discriminate between direct effects of RARs in a given NCC 
population and indirect effects mediated by RARs in neighbouring cell populations. In the 
present work, we have investigated the phenotypes of somatic mutants lacking RAR!, RAR" 
and/or RAR#, selectively in NCC and demonstrated that RARs exerts a dual function during 
craniofacial development. We show that within the frontonasal mass, RAR! and RAR# act 
cell-autonomously in NCC to determine the morphogenesis of NCC-derived elements. In 
contrast, RARs appear mostly dispensable in cranial NCC giving rise to BA2-6 derived 
tissues, suggesting that they predominantly exert their role in another embryonic cell 
population such as the BA endoderm. 
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METHODS 
Mice. All mice, with a mixed C57BL/6–129/Sv (50%:50%) genetic background, were housed 
in an animal facility licensed by the French Ministry of Agriculture (agreement N°B67–218–
5), in compliance with the European legislation on care and use of laboratory animals. 
Heterozygous mice were mated overnight, and animals with a vaginal plug at noon of the next 
day were considered as embryonic day (E) 0.5. The generation and genotyping of loxP-
flanked Rara (Rara+/L2), Rarb (Rarb+/L2) and Rarg (Rarg+/L2) have been described (Chapellier 
et al., 2002a; Chapellier et al., 2002b; Chapellier et al., 2002c). The Wnt1-Cre mouse, which 
carries a transgene containing a Cre cassette under the control of the Wnt1 promoter, and the 
R26R reporter mouse, which expresses E. coli ß-galactosidase upon Cre-mediated excision of 
a loxP-flanked intervening DNA sequence, were obtained from A. McMahon and P. Soriano, 
respectively (Danielian et al., 1998; Soriano, 1999). The Wnt1-Cre, Rara+/L2, Rarb+/L2 and/or 
Rarg+/L2 parental lines were intercrossed to generate mutant embryos and fetuses lacking 
RAR! and RAR" or RAR! and RAR# in NCC (hereafter designated as Rara/bNCC-/- and 
Rara/gNCC-/-, respectively) and lacking all three RARs in NCC (hereafter designated as 
Rara/b/gNCC-/- mice). Littermate embryos without the Wnt1-Cre transgene were used as 
controls (hereafter designated as WT). All mutants were obtained at a Mendelian ratio at 
birth. 
Phenotyping of embryos and fetuses. For histology, samples were fixed in Bouin’s fluid for 
5 days, embedded in paraffin, serially sectioned and stained with Mallory’s trichrome (Mark 
et al., 1993). Skeletons were stained with alcian blue and alizarin red. For "–galactosidase 
activity, detection was performed as described (Rossant et al., 1991). In situ RNA 
hybridization was carried out as described (Matt et al., 2003). The digoxigenin–labeled 
antisense riboprobes were synthesized using cDNA templates (references upon request). 
Terminal transferase–mediated dUTP-Nick-End-Labeling (TUNEL) was performed using the 
Apoptag® kit (Chemicon International) on 7µm-thick serial frontal sections from paraffin-
embedded embryos. 
Cell proliferation was assessed on 7µm-thick serial histological sections using the anti-
phosphohistone H3 antibody (Sigma). The number of positive cell nuclei was determined by 
counting more than 2000 frontonasal cells on each section at the rate of 20 sections by 
embryo. 
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RESULTS 
Ablation of the three RARs in NCC does not alter their migration 
We first tested whether inactivation of all three RARs in the neural crest lineage (i.e., in 
Rara/b/gNCC-/- mutants) altered migration of NCC from the neurectoderm into the frontonasal 
process and BAs. For this purpose, we used the reporter line (R26R-LacZ), which is expressed 
in the progeny of the NCC that have undergone Cre-mediated recombination (Jiang et al., 
2000). At E9.5, both mutant and WT embryos possessed 4 BAs, three of which (BA1 to BA3) 
have externally visible bulges (Fig. 1a,b). Importantly, the pattern of ß-galactosidase activity, 
identifying NCC in the frontonasal process and BAs, was identical in E9.5 Rara/b/gNCC-/- 
mutants and in control Wnt1-cre/R26R embryos (Fig.1a-f). At E9.5, normal BAs consisted of 
a core of paraxial mesoderm centred by an aortic arch artery, surrounded by NCC and covered 
externally with ectoderm and internally with endoderm (Fig. 1e). This BA organization was 
present in Rara/b/gNCC-/- embryos, with histologically normal endoderm and ectoderm (n=2; 
Fig. 1e-f). To further analyse the migration and patterning of NCC in mutant embryos, we 
performed whole mount in situ hybridizations using two markers of migrating NCC, Crabp1 
and Dlx5 (Dencker et al., 1990; Depew et al., 1999). We found a normal distribution of 
Crabp1 and Dlx5 in E9.5 Rara/b/gNCC-/- mutants (Fig. 1g-j). Lastly, to confirm that 
segmentation of the BAs occurred correctly in Rara/b/gNCC-/- mutants, we analysed the 
distribution of Pax1 transcript, which is expressed in the pharyngeal pouch endoderm 
(Deutsch et al., 1988). As shown in figure 1, Pax1 was normally expressed in E9.5 
Rara/b/gNCC-/- mutants (n=2; Fig. 1k-l). Altogether, these data clearly indicate that ablation of 
all RARs in NCC affect neither their specification and migration, nor the formation of the 
BAs. 
Ablation of the three RARs in NCC does not alter the development of cranial nerve 
ganglia 
To assess whether removing all three RARs in NCC affected the development of cranial 
nerves, we compared the axonal paths using antineurofilament immunostaining in E10.5 WT 
and Rara/b/gNCC-/- mutants. Additionally, we analysed the expression of Sox10, a marker of the 
neurogenic NCC (Kuhlbrodt et al., 1998). We detected identical patterns of neurofilament 
distribution and of Sox10 expression in WT and Rara/b/gNCC-/- embryos at E10.5 (n=2; Fig. 
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1m-p). These data indicate that ablation of RARs in NCC does not alter the fate of their neural 
derivatives. 
RAR!  and RAR#  function in cranial NCC is necessary for the formation of most of the 
frontonasal skeletal elements 
At E9.5, Rara/b/gNCC-/- mutants were morphologically normal (Fig. 1a-b). However, at birth, 
Rara/b/gNCC-/- mutant mice displayed a truncated face and a mid-facial cleft (n=6; Fig. 2c,d), 
similar to that described in Rara/g-null mutants although exencephaly was not observed 
(Lohnes et al., 1994). Skeletal analysis of E18.5 Rara/b/gNCC-/- fetuses revealed agenesis or 
malformations of NCC-derived craniofacial bones and cartilages (Noden, 1988; Le Douarin et 
al., 1993; Chai and Maxson, 2006; Gross and Hanken, 2008; McBratney-Owen et al., 2008; 
Yoshida et al., 2008). Large portions of frontal bones were missing; the premaxilla, palatal 
process of premaxilla and nasal cartilage were rudimentary; the upper incisors were absent, 
the presphenoid bone hardly distinguishable, and the basisphenoid bone was deformed in its 
anterior part. In contrast, the more posterior structures derived from paraxial mesoderm, i.e. 
the different parts of the occipital (basi-, exo-, supraoccipital) bone were normal (Table 1; 
Fig. 2e-i). However, the parietal bone also derived from the mesoderm was reduced (Fig. 2i). 
The interparietal bone that has a dual origin: its medial portion being crest-derived, and its 
lateral portion mesoderm-derived (Jiang et al., 2002b), was normal in Rara/b/gNCC-/- fetuses 
(Fig. 2i). Rara/b/gNCC-/- mutants also exhibited a supernumerary skeletal element previously 
detected in Rara/g-null mutants, separating the trigeminal ganglion from the brain. This 
element corresponds to a reminiscent of the pila antotica, a structure that was lost during 
evolution from reptiles to mammals (Table 1, data not shown) (Lohnes et al., 1994; 
Ghyselinck et al., 1997; Mark et al., 1998). Analysis of Rara/gNCC-/- fetuses revealed an 
extensive loss of NCC-derived craniofacial skeletal elements undistinguishable from that seen 
in Rara/b/gNCC-/- mutants. Contrasting with the multiple frontonasal skeletal deficiencies seen 
in Rara/gNCC-/- and Rara/b/gNCC-/- mutants, alteration of a single skeletal element was observed 
in RargNCC-/- mutants, corresponding to a severe hypoplasia of the presphenoid bone (fig2j-k). 
Rara/bNCC-/- mutants did not show abnormalities in the frontonasal region (Table 1). 
Altogether, these observations indicate that RAR! and RAR# act cell-autonomously within 
the frontonasal mass NCC-derived mesenchyme to direct the morphogenesis of skeletal 
elements, whereas RAR" is not involved in this process. 
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All derivatives of the first and second BA are present in Rara/b/g
NCC-/- 
mutants 
In Rara/b/g
NCC-/- 
mutants, the dentary (mandibular) bone, Meckel’s cartilage and malleus, all 
deriving from the mandibular portion of the BA1, were normal (Table 1 and Fig. 2e-i). 
Conversely, the maxillary bones, as well as the alisphenoid, squamosal, incus, tympanic bone 
and gonial bone, were present although misshapen. The maxillary, the alisphenoid and the 
squamosal bone were reduced (Table 1 and Fig. 2e-i). The short process of the incus (SI) was 
conspicuously larger than in WT, a defect also observed in all RaraNCC-/- mutants (Fig. 2l). The 
tympanic ring was shortened and the gonial bone distorted. This atypical gonial bone was also 
observed in Rara/bNCC-/- mutants; it was the only skeletal malformation associated to the 
inactivation of both Rara and Rarb in NCCs.  
A pterygoquadrate element (i.e., a skeletal element connecting the alisphenoid bone and the 
incus) was never observed in Rara/b/g
NCC-/-
 mutants (Table 1), whereas it was found in 
Rara/g-null and Rara/b-null mutants (Lohnes et al., 1994; Ghyselinck et al., 1997). The 
cartilaginous derivatives of the 2
nd
 branchial arch, i.e. the stapes, the styloid and the lesser 
horn of the hyoid bone (Noden, 1988; Le Douarin et al., 1993; Santagati and Rijli, 2003) were 
normal in Rara/b/g
NCC-/-
 mutants (Table 1). The otic capsule, which has a dual embryological 
origin from ectoderm and NCC (Torres and Giraldez, 1998; O'Gorman, 2005) was also 
normal. Agenesis of the pinna (the externally visible portion of the outer ear) was never 
observed in Rara/b/gNCC-/- mutants (Fig. 2a-c) although it was found in Rara/g-null mutants 
(Lohnes et al., 1994). Thus, the mild craniofacial skeletal defects of the 1
st 
BA maxillary 
derivatives previously seen in Rara/g-null mutants were also observed in Rara/b/g
NCC-/- 
mutants. However, the severe craniofacial defects of the 1
st 
BA mandibular derivatives and of 
the 2nd BA derivatives observed in Rara/g-null mutants were not recapitulated in  
Rara/b/g
NCC-/- 
mutants (Table 1). Altogether, these data indicate that RARs are not involved in 
NCC for the initial specification of the 1st and 2nd BA derivatives, but rather play a role later in 
the morphogenesis of some skeletal elements of the 1st and 2nd BA derivatives. 
Ablation of RARs in NCC yields relatively few defects in tissues derived from the post-
otic BA 
We next investigated the status of the great cephalic arteries (i.e., arch of the aorta, subclavian 
and common carotid arteries), the aorticopulmonary septum, the thymus and the parathyroid 
glands, as their normal development is supported by the cardiac NCC and they were found to 
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be severely altered and/or deficient in Rara/b- and Rara/g-null mutant mice (Lohnes et al., 
1994; Mendelsohn et al., 1994; Ghyselinck et al., 1997). About half of the Rara/b/gNCC-/- 
mutants (3 out of 7) displayed a patterning defect of the great arteries consisting of an 
abnormally positioned aortic arch on the right side of the midline and associated with a 
persistent truncus arteriosus (PTA) and an interventricular septal defect (Fig. 3a, b and 
Table 2). Along the same lines, one third of the Rara/gNCC-/- mutants, exhibited a 
retroesophagal subclavian artery (2 out of 6; Table 2). In contrast, Rara/bNCC-/- mutants never 
exhibited defects of the great arteries (n=6). Notably, Rara/b/gNCC-/-, Rara/gNCC-/- and 
Rara/bNCC-/- mutants never displayed developmental defects of the thymus and thyroid derived 
from the posterior branchial arch arteries (Table 2). However, the parathyroid glands were 
always found more rostrally than expected, i.e. never associated with thyroid gland, in 
Rara/b/gNCC-/- mutants at E18.5 (n=3; Fig. 2j-l). One can also note that, despite a normal shape 
of the hyoid bone, a fusion between the hyoid greater horn and the rostral horn of the thyroid 
cartilage was consistently observed in Rara/gNCC-/- and Rara/b/gNCC-/- mutants (Fig. 3c-d). 
Altogether, these data indicate that RAR! and RAR#, but not RAR", have a function in NCC 
for the proper formation of the post-otic BA derivatives. 
Ablation of RAR! and RAR# alters the apoptotic pattern in the frontonasal area 
In E10.5 Rara/b/gNCC-/- mutants, the nasolateral and nasomedial processes were present on 
either side of the olfactory pit. However, at E11.5, these processes are spaced more laterally 
than in the WT situation (compare double-arrows in Fig. 4). The abnormally wide spacing 
became more pronounced later during development and result in defective merging of the 
nasomedial processes in the midline. These observations suggest that ablation of RARs in 
NCC impacted the medial expansion of the nasal processes, possibly through regulation of 
cell proliferation or apoptosis. Cell proliferation was assessed at E10.5 and E11.5 using an 
anti-phosphohistone H3 (PHH3) antibody (a marker of the M-phase of the cell cycle). In the 
frontonasal mesenchyme of E10.5 WT, the number of PPH3-positive cells was 132+/-15 for 
2000 counting cells (n=4) versus 144+/-17 (n=2) in Rara/b/gNCC-/- mutants. At E11.5 
Fig. 5a,e), the number of PPH3-positive cells in the frontonasal region of the WT (n= 4) was 
160+/-22 versus 154+/-25 in Rara/b/gNCC-/- mutants (n=3). Therefore cell proliferation in the 
frontonasal region was not significantly affected by ablation of RARs in the NCC. 
The frontonasal region of E10.5 WT embryos displayed, similarly to E11.5 embryos, a cluster 
of TUNEL-positive cells in the dorsal region of the nasal process (arrowheads in Fig. 5b,d). 
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Apoptosis was assessed at E10.5 and E11.5 on serial histological sections. At E10.5, out of 30 
sections through the entire frontonasal region the apoptotic cluster was consistently observed 
in WT and Rara/b/gNCC-/- mutants (n=3; Fig. 5b,f). Therefore, at E10,5, no significant change 
was observed for the distribution of apoptotic cells in the frontonasal region of Rara/b/gNCC-/- 
mutants. In E11,5 WT embryos, the large cluster of TUNEL-positive cells located dorsally to 
the nasal pits was detected on at least 35 consecutives serial sections (n=7; arrowheads in Fig. 
5d). In Rara/b/gNCC-/- mutants (n=2; Fig. 5h) and Rara/gNCC-/- mutants (n=2), this cluster was 
not detected. Only a few scattered apoptotic cells were observed (arrows in Fig. 5h). 
Altogether, these data indicate that apoptosis in the frontonasal mesenchyme is controlled by 
RAR! and RAR#. At E11.5, we also identified on WT embryos a single cluster of apoptotic 
cells located on the midline (n=7; brackets in Fig. 5c), which was replaced by two smaller 
apoptotic clusters on each side of the midline in Rara/b/gNCC-/- (n=2) and Rara/gNCC-/- mutants 
(n=2; Fig. 5g). This difference can be accounted for by the abnormal wide space between the 
2 nasomedial processes in Rara/b/gNCC-/- mutants.  
 
DISCUSSION 
Although, the crucial role of RARs in NCC-derived craniofacial structures has been 
established for years (Lohnes et al., 1994; Ghyselinck et al., 1997; Mark et al., 2009), 
evidence that this role could be cell autonomous was still lacking. The difficulty of 
understanding the functions of RARs in NCC originated from several problems. Firstly, 
conventional germline RAR compound null mutants display a broad spectrum of 
abnormalities affecting a variety of organs constituted by cells of multiple origins. Secondly, 
RARs exhibit widespread and rapidly changing expression patterns in the developing embryo 
(Dollé, 2009), and RA is a secreted molecule which can act in a paracrine manner (Matt et al., 
2005; Duester, 2008; Matt et al., 2008; Niederreither and Dollé, 2008). To overcome these 
difficulties and to gain insights into the functions of RA, it was necessary to produce and 
analyse mice in which RARs were specifically ablated in NCC. 
RAR!  and RAR# exert cell-autonomous function in frontonasal NCC 
The present work shows that somatic inactivation of Rara and Rarg in NCC (i.e., Rara/gNCC-/- 
mutants) phenocopies almost all the abnormalities displayed by the corresponding germline 
null mutants (i.e., Rara/g-null mutants) in the frontonasal skeletal elements, namely the 
 11 
frontal, nasal, premaxillary, presphenoid, and basisphenoid bones, as well as in the upper 
incisors (Lohnes et al., 1994). This demonstrates that RAR! and RAR# are cell-autonomously 
implicated in the development of the NCC-derived frontonasal skeletal elements. Besides, as 
RargNCC-/- mutants display severely reduced presphenoid bones, RAR# is predominantly 
involved in the formation of this bone. 
Additionally, the supraoccipital and interparietal bone appear normal in Rara/gNCC-/- mutant 
mice, while they are severely affected in Rara/g-null mutants. These observations suggest that 
RAR! and RAR# also exert a function in the mesodermal mesenchyme, as the supraoccipital 
bone and the lateral portion of the interparietal derive from the mesoderm (Chai and Maxson, 
2006). Interestingly, the mesoderm-derived parietal bone is reduced in Rara/gNCC-/- mutants, 
suggesting that it may be the result of a defect in the underlying NCC-derived meninges 
(Jiang et al., 2002b). 
It is noteworthy that the otic capsule is normal in Rara/gNCC-/- mutant mice, while severely 
malformed in Rara/g-null mutants (Lohnes et al., 1994). As this structure is derived both from 
mesoderm and NCC (Torres and Giraldez, 1998; O'Gorman, 2005) these observations suggest 
that the mesoderm can construct a normal otic capsule without involvement of RARs in the 
NCC. 
The additional ablation of Rarb (yielding Rara/b/gNCC-/- mutants) does not increase the 
severity or penetrance of the craniofacial skeletal defects, but induces severe ocular 
malformations (Matt et al., 2008 for a full description). This is accounted for by the functional 
redundancy between Rarb and Rarg in the periocular mesenchyme (Matt et al., 2005; Matt et 
al., 2008), rather than in the bone anlagen (present study). Thus, our data show that RAR! 
and RAR# are the functional receptors transducing the RA signal in frontonasal NCC.  
RAR!  and RAR# functions are fulfilled after the cessation of NCC migration 
We show that NCC lacking all RARs are able to migrate into the frontonasal process and 
BAs, according to normal paths, as assessed from the distribution of Crabp1 transcripts and 
from the NCC-specific ß-galactosidase activity in Rara/b/gNCC-/- mutants. Therefore, RARs are 
dispensable in NCC for their migration and survival until E10.5. However at E11.5, the nasal 
processes develop too widely apart and fail to fuse, eventually causing a wide midline cleft by 
E18.5. To understand at a cellular level the basis of the aberrant anatomy of E11.5 mutants, 
we analyse cellular processes underlying growth of the nasal prominences by measuring 
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proliferation and cell death. We could not detect any significant differences in proliferation. 
However, the widespread cell death normally occurring in E11.5 WT frontonasal 
mesenchyme is absent in Rara/b/gNCC-/- and in Rara/gNCC-/- mutants, indicating that RAR! and 
RAR# mediate, without any contribution from RAR", apoptosis during frontonasal 
mesenchyme maturation. 
A failure of RA-induced physiological cell death in the frontonasal processes may be one of 
the mechanisms to account for the abnormal lateral position of the nasal processes. As the 
crucial merging of the facial primordial processes depends on their proper outgrowth, a 
change in the critical mass is likely to compromise this process. We cannot exclude the 
possibility that other mechanisms may also participate to this phenotype, however this 
impaired apoptosis constitutes an additional example illustrating a RAR-dependent cell-death 
process acting to sculpt the embryo. Analogous situations have been observed during heart, 
eye and limb and development (Ghyselinck et al., 1998; Dupé et al., 1999a; Matt et al., 2005; 
Rodriguez-Guzman et al., 2007). 
RA activating RAR!  and RAR#  in frontonasal NCC is likely from (neuro)ectodermal 
origin  
A local source of RA in the chick rostral head initiates a regulatory cascade that coordinates 
frontonasal process morphogenesis (Schneider et al., 2001). Similarly, in mice, expression 
pattern analyses have indicated that the RA-synthesizing enzyme ALDH1A2 is transiently 
expressed in the prospective forebrain neuroectoderm (Wagner et al., 2000; Smith et al., 
2001), while ALDH1A3 is expressed later in the facial ectoderm (Mic et al., 2000) and 
ALDH1A1 is only expressed in the eye (McCaffery et al., 1991). In addition, craniofacial 
defects similar to those displayed by Rara/gNCC-/- mutants have been described in 
Aldh1a2/Aldh1a3 compound null mutants (Halilagic et al., 2006). These data, together with 
the present results, suggest that RA synthesized by ALDH1A2 then by ALDH1A3 in 
(neuro)ectodermal tissues may control the morphogenesis of the frontonasal process through 
diffusing towards the neighbouring RAR!- and RAR#-expressing NCC-derived mesenchyme. 
In this context, RA would act in a paracrine manner to pattern the skeletogenic frontonasal 
NCC. Interestingly, a similar situation has been observed in the developing ocular region: RA 
is synthesized by the retinal pigmented epithelium, the retina and the corneal ectoderm [all 
derived from the (neuro)ectoderm], and it orchestrates eye morphogenesis through diffusing 
to the NCC-derived periocular mesenchyme where it activates RXR/RAR heterodimers. 
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Surprisingly, during these two processes RARs would have no autonomous function in the 
ectodermal tissues (Matt et al., 2005; Matt et al., 2008). 
RARs are not required in NCC for the formation of branchial arches 
The BA2 to BA4 are hypoplasic in Rara/g- and Rara/b-null mutants (Lohnes et al., 1994; 
Ghyselinck et al., 1997; Dupé et al., 1999b; Wendling et al., 2001), indicating that formation 
of these structures is RAR-dependent. The hypoplasia or absence of posterior BA in embryos 
deficient for RA signalling is correlated with changes in Hoxa1, Hoxb1, Pax1 and Pax9 gene 
expression in the endoderm (Dupé et al., 1999b; Wendling et al., 2000; Niederreither et al., 
2003; Vermot et al., 2003). Since Hoxa1 and Hoxb1 are direct RA-target genes (Dupé et al., 
1997; Huang et al., 1998), and considering that BA endoderm is a primary target tissue of 
RA-induced teratogenesis (Matt et al., 2003; Vieux-Rochas et al., 2007), a model in which 
RARs in the endoderm regulate the formation of the pharyngeal pouches has been proposed 
(Mark et al., 2004; Vieux-Rochas et al., 2007). 
As Pax1 is severely down-regulated in the endoderm of Rara/g- and Rara/b-null mutants, we 
have tested its expression in Rara/b/gNCC-/- and observed a normal expression pattern. In 
addition, by observing histological section of E9.5 embryos, we show that the formation of 
BA2 to BA4 is essentially not affected in Rara/b/gNCC-/- embryos. Therefore, these two data 
unambiguously demonstrate that NCC do not represent the main target tissue of RARs during 
BA formation. Along the same lines, we have previously shown in Rara/b-null mutants that 
RAR! and RAR" are together essential for the organization of the NCC-derived post-otic 
cranial nerve and of their distal ganglia (Dupé et al., 1999b; Wendling et al., 2001). 
Surprisingly, cranial nerves of Rara/b/g
NCC-/- 
mutants are not affected, thereby indicating that 
RAR do not fulfil cell-autonomous functions in the patterning of neurogenic NCC. 
RARs are largely dispensable in NCC for the early morphogenesis of BA-derived 
structures 
In Rara/g-null mutants, the formation of BA1 is unaffected (Wendling et al., 2001). 
Accordingly, BA1-derivatives are all identifiable although some of them are misshapen. We 
previously proposed that this can be accounted for by the severe malformations of the 
neighbouring (i) mid-facial skeletal elements (as to defects of the maxillary, squamosal and 
alisphenoid bone) and (ii) otic capsule (as to defects of the malleus, meckel, incus cartilages). 
In addition, more anterior structures derived from the mandibular portion of BA1 (i.e., 
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dentary bone, mandibular molars and incisors) are unaffected (Lohnes et al., 1994; 
Ghyselinck et al., 1997). In Rara/b-null mutants, the cranium is essentially normal (Lohnes et 
al., 1994; Ghyselinck et al., 1997). 
The present study shows that in Rara/b/gNCC-/- mutants, maxillary BA1-derived structures 
including the maxillary, alisphenoid and squamosal bones are well recognizable, but generally 
reduced, similar to Rara/g-null mutants. The presence of these misshapen bones may illustrate 
a RAR requirement in NCCs during later developmental process such as the modelling of 
skeletal elements. Indeed, the enlargement of the short process of the incus displayed also by 
RaraNCC-/- mutants demonstrates that RARs are important in NCC for sculpting the 
morphology of skeletal element. 
In contrast, in Rara/b/gNCC-/- mutants, mandibular BA1-derived structures including Meckel’s 
cartilage and malleus appear normal. Thus, this observation suggests that the severely 
malformed malleus and Meckel cartilages previously described in Rara/g-null mutants may 
be explained by the severe malformation of the otic capsule. In contrast, the gonial and 
tympanic bones are still distorted in Rara/gNCC-/- mutants, it suggests that RAR! and RAR# 
have a function in modelling these two bones. Since we observe discrete cranial skeletal 
irregularities, we propose that early morphogenesis of BA1-derived structures does not rely 
on RARs in NCC. Nevertheless, RARs in NCC are important later for sculpting the 
morphology of the skeletal components of the head. It may represent an important mechanism 
for driving morphological changes in facial architecture during evolution. Such a mechanism 
is reinforced by experiments implicating elevation of RA that also lead to skull and face bone 
defects (Vieux-Rochas et al., 2007; Maclean et al., 2009). In both Rara/g- and Rara/b-null 
mutants, the alisphenoid and incus, which are derived from the maxillary process of BA1, are 
fused through a supernumerary piece of cartilage to form a pterygoquadrate element that has 
been lost during mammalian evolution (Mark et al., 1998). Intriguingly, the pterygoquadrate 
is never observed in Rara/b/gNCC-/- mutants, suggesting that RARs are required in a tissue (or a 
cell-type) distinct from NCC to allow involution of this atavistic structure of the upper jaw 
(Mark et al., 1998).  
In contrast to BA1, the initial formation of BA2 is impaired in Rara/g-null mutants (Wendling 
et al., 2001), and BA2-derived elements (i.e., the stapes, hyoid lesser horn, styloid bone and 
pinna) are consequently severely malformed (Lohnes et al., 1994). We show in the present 
study that BA2 is properly formed in Rara/b/gNCC-/- embryos and that none of its derivatives 
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are affected. Thus, RAR-depleted NCC can differentiate normally into cartilage and their 
initial patterning is unaltered. Altogether these findings demonstrate that RARs are 
dispensable in NCC for the formation of BA2-derived structures, suggesting thereby that they 
predominantly exert their role in a cell population distinct from NCC. 
Rara/b–null and Rara/g–null mutants display the complete set of defects that can be 
generated in the chick by surgical ablation of post–otic NCC normally migrating in BA3-
BA4, namely aberrant patterning of great arteries, together with persistent truncus arteriosus 
(PTA) and interventricular septal defects, and thymus and parathyroid gland ageneses or 
ectopia (Hutson and Kirby, 2003). Post-otic mesenchymal NCC also contribute to the body of 
the hyoid bone and the thyroid cartilages (Kontges and Lumsden, 1996; Santagati and Rijli, 
2003). Interestingly, the defects in the patterning of great arteries, which are severe and 
consistently observed in Rara/b- and Rara/g-null mutant (Mendelsohn et al., 1994; 
Ghyselinck et al., 1997), occur with a low penetrance in Rara/b/gNCC-/- fetuses. Furthermore, 
BA4 appears to be the most affected BA, since the defects in great arteries observed (i.e. the 
right aortic arch and the retroesophagal subclavian artery), result from remodelling of the 4th 
aortic arch. In addition, all the neck glands (i.e., thymus, thyroid and parathayroids) are 
present in Rara/b/gNCC-/- fetuses (Ghyselinck et al., 1997). Finally, contrary to the situation in 
Rara/b-null mutants, the shapes of the hyoid bone and of the laryngeal cartilages are normal 
in Rara/b/gNCC-/- fetuses, with the notable exception of a fusion between the greater horn of the 
hyoid bone and the rostral horn of the thyroid cartilage, which are also BA4-derived 
structures. 
The present work thus indicates that RARs have a cell-autonomous function in NCC during 
the development of a few given post-otic BA-derived structures, mainly those derived from 
the BA4. However, the overall study clearly shows that RAR-dependent formation of most of 
the post-otic BA-derived structures does not rely on the presence of RARs in NCC. A 
previous study, based on pharmacological study (Matt et al., 2003), favoured a model in 
which the main function of RARs in BA2 to BA6 was taking place in the pharyngeal 
endoderm; the present genetic study clearly demonstrates its physiological relevance. 
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FIGURE LEGENDS 
Fig. 1: Comparison of neural crest cells distribution in E9.5 wild type (WT) and 
Rara/b/gNCC-/- mutant embryos. (a-f) Distribution of ß-galactosidase activity in mice 
harbouring both R26R and Wnt1-Cre transgenes. The "-galactosidase staining in WT and 
Rara/b/gNCC-/- is undistinguishable in (a,b) whole embryo preparations and (c-f) histological 
sections. (g-n) In situ hybridization analyses: (g,h) Crabp1 and (i,j) Dlx5 expressions are 
normal in branchial arches of Rara/b/gNCC-/- mutants, while (k,l) expression of Pax1 
demonstrates that the branchial arches are normally segmented. (m-p) Analysis of cranial 
nerves using: (m,n) Sox10 as a molecular marker and (o,p) an anti-neurofilament antibody 
demonstrate a normal pattern of the cranial nerves and associated ganglia in Rara/b/gNCC-/- 
mutants. Abbreviations. A1-A3: aortic arches 1-3; B1-B6: branchial arches 1-6; EN: BA 
endoderm; EC: BA ectoderm; F: frontonasal mesenchyme; FB: forebrain; H: heart; M: 
mesoderm; NP: nasal process;  P1-P3: pharyngeal pouches 1-3; G5: trigeminal ganglion; 
G7/8: facial-acoustic ganglion; N9: 9th cranial nerve; N10: 10th cranial nerve. 
 
Fig. 2: Craniofacial defects in Rara/b/gNCC-/- mutants. (a-d) Heads of (a) WT, (b) Rara/gNCC-
/- and (c,d) Rara/b/gNCC-/- E18.5 fetuses. White arrowheads (in a-b) point to the eye and the 
asterisk indicates the absence of externally visible eye structures (Matt et al., 2008). Black 
arrowheads (in b-d) point to the median facial cleft. (e-l) Skeletal preparations of heads from 
E18.5 WT, Rara/b/gNCC-/-, RargNCC-/- and RaraNCC-/- mutants (genotypes indicated in panels). 
(e,f) Lateral view; (g,h) Ventral view. In (f) the asterisk indicates the hypoplasic frontonasal 
skeleton. In (i), comparative view of dissected bones. Interparietal and dentary bones are 
normal. Mutants have smaller parietal, frontal and squamosal bones. Tympanic and gonial 
bones are distorted. In (k) the asterisk indicates the severely reduced presphenoid bone of the 
RargNCC-/- mutant. In (l) note the lengthening of the caudal process (CI) of the RaraNCC-/- 
mutant incus. Abbreviations: AL: alisphenoid bone; BO: basioccipital bone; BS: basisphenoid 
bone; CI: caudal process of the incus; D: dentary (mandibular) bone; E: exoccipital bone; EE: 
external ear; F: frontal bone; G: gonial; I: interparietal bone; N: nasal bone; O: otic capsule; P: 
parietal bone; PS: presphenoid bone; PX: premaxillary bone; S: supraoccipital bone; SI: 
stapedial process of the incus; SQ: squamosal bone; TB: tympanic bone; X: maxillary bone. 
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Fig. 3: Cardiovascular and glandular defects in Rara/b/gNCC-/- mutants. Histological 
sections of the heart outflow tract region of E14.5 fetuses show separated aortic (AO) and 
pulmonary (PT) trunks in (a) WT, whereas (b) Rara/b/gNCC-/- mutants exhibit an unseptated 
outflow tract (i.e., a persistent truncus arteriosus; PTA). (c-e) Histological sections through 
the thyroid gland region of (c) WT and (d-e) Rara/b/gNCC-/- E18.5 fetuses, showing (d) a lack 
of parathyroid glands within the thyroid glands in the mutant and (e) their ventral ectopia. (k) 
The black asterisk indicates an ectopic cartilage connecting the body of the hyoid bone to the 
thyroid cartilage. Abbreviations: AO: aorta; H: body of the hyoid bone; LH: lesser horn of the 
hyoid bone; PT: pulmonary trunk; PTA: persistent truncus arteriosus; PTh: parathyroid 
glands; T: thyroid cartilage; Th: thyroid gland. 
 
Fig. 4: E11.5 Rara/gNCC-/- and Rara/b/gNCC-/- mutants present a median facial cleft. (a,b) 
Heads of E11.5 (a) WT and (b) Rara/gNCC-/- embryos. Double-headed black arrows point to the 
distance between the nasal placodes. FB: forebrain; NP: nasal process. 
 
Fig. 5: Ablation of RARs in neural crest cells decreases apoptosis in the frontonasal 
mass. (a,e) Distribution of proliferating cells (as assessed by phosphohistone H3 
immunodetection) in E11.5 (a) WT and (e) Rara/b/gNCC-/- embryos. (b-d, f-h) Distribution of 
apoptotic cells (as assessed by TUNEL assays) at E10.5 (b,f) and E11.5 (c,d,g,h). Brackets (in 
c and g) indicate clusters of apoptotic cells in the midline region. Black arrowheads (in b,d) 
indicate clusters of apoptotic cells located in the dorsal frontonasal area of WT embryos. 
Abbreviations. F: frontonasal mesenchyme; FB: forebrain; GE: ganglionic eminence; H: 
heart; M: maxillary primordium; MD: mandibular primordium; N: nasal cavity; NP: nasal 
process. 
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Table 1: Malformations of cranial skeletal elements in RarNCC-/- mutants compared to the 
Rar-null compound mutants observed at E18.5. Legend. *: abnormality present in a 
majority of the mutants; #: abnormality fully penetrant; (1) Lohnes et al., 1994 and 
Ghyselinck et al., 1997. 
 
 
Genotypes of RarNCC-/- and Rar-null compound 
mutants showing similar defects 
Abnormalities 
Compound RarNCC-/- 
mutants 
Compound Rar–null 
mutants(1) 
Posterior structures of the head   
• Supraoccipital and interparietal bone reduced 0 Rara/g
#
 
• Parietal bone reduced Rara/b/gNCC-/-
#, Rara/gNCC-/-# Rara/g# 
• Exencephaly  0 Rara/g 
Midfacial skeletal elements   
• Frontal bone, premaxillary bone and nasal 
capsule severely reduced. 
Rara/b/gNCC-/-
#, Rara/gNCC-/-# Rara/g# 
• Agenesis of the presphenoid bone and 
metoptic pilar. 
Rara/b/gNCC-/-
#, Rara/gNCC-/-#, 
RargNCC-/-
#
 
Rara/g
#, Rarg* 
• Pila antotica Rara/b/gNCC-/-*, Rara/gNCC-/-* Rara/g# 
First branchial arch-derived elements   
Maxillary derivatives :   
• Maxillary, squamosal and alisphenoid reduced Rara/b/gNCC-/-
#, Rara/gNCC-/-# Rara/g# 
• Enlarged short process of the incus 
Rara/b/gNCC-/-
#, Rara/gNCC-/-#, 
RaraNCC-/-
#, Rara/bNCC-/-#, 
Rara, Rara/g
#
, Rara/b 
• Ptrerygoquadrate cartilage 0 Rara, Rara/g
#
, Rara/b 
Mandibular derivatives :   
• Severely malformed Malleus and Meckel 
cartilage 
0 Rara/g
#
 
• distorted gonial bone  
Rara/b/gNCC-/-
#, Rara/gNCC-/-#, 
Rara/bNCC-/-, 
Rara/b/g
#, Rara/g#, 
Rara/b, 
• Mild hypoplasia of the tympanic bone  Rara/b/gNCC-/-
#, Rara/gNCC-/-# Rara/g 
Second branchial arch-derived elements   
• Stapes, styloid and lesser horn of the hyoid 
bones highly malformed 
0 Rara/g
#
 
• Agenesis of the pinna (external ear auricle) 0 Rara/g
#
 
Abnormal laryngeal cartilages   
• Body of the hyoid bone fused to the thyroid 
cartilage 
Rara/b/gNCC-/-
#, Rara/gNCC-/-# Rara/g# 
• Malformed arytenoid and cricoid cartilage 0 Rara/g
#
, Rara/b
#
 
• small otic capsule  0 Rara/g
#
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Table 2: Cardiovascular and glandular abnormalities in RarNCC-/- mutants. Legend. + : 
presence of ectopic parathyroid gland, percentage not determined. (1) Lohnes et al., 1994; (2) 
Ghyselinck et al., 1997. Cardiovascular defects were evaluated at E14.5 and E18.5 whereas 
glandular defects were evaluated at E18.5. 
 Mutant genotypes 
Abnormalities Rara/gNCC-/- Rara/b/gNCC-/- Rara/bNCC-/- Rara/g(1) Rara/b(2) 
• Persistent truncus arteriosus 0/6 3/7 0/6 100% 100% 
• Abnormal aortic arch 4 2/6 3/7 0/6 100% 100% 
• High ventricular septal defect 0/6 3/7 0/6 100% 100% 
• Thymus agenesis or ectopia  0/3 0/3 0/2 100% 50% 
• Thyroid hypoplasia or ectopia  0/3 0/3 0/2 80% 20% 
• Parathyroid gland ectopia 0/3 3/3 0/2 + + 
 
